Cambridge, Massachusetts | August 2021
Clear Scientific has received continued support from a government agency to develop a biotherapeutic agent to scavenge and sequester nerve agents in the human body. This effort is focused on scale up and testing of a longer-lasting enzyme that can act as a prophylactic and/or therapeutic against pesticides and nerve agent poisoning. This technology has the potential to provide multi-day or week-long protection.
Cambridge, MA | February 2023 Clear Scientific was featured in this @BloombergLaw article on promising therapies for treating drug overdose. We are developing sequestrant-based therapeutics to addres
Cambridge, MA | December 2022 Shekar Shetty, Clear Scientific Inc.’s CEO, gave an update on our first- in-class therapeutic agent CS-1103 to treat methamphetamine overdose at the Behavioral Health Ca
Boston, MA | October 2022 Team Clear was honored to join hundreds of participants to raise funding and complete a 5K walk to support and raise awareness for the non-profit organization Shatterproof. S